316 related articles for article (PubMed ID: 24720924)
21. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Pfeffer MA; McMurray JJ; Velazquez EJ; Rouleau JL; Køber L; Maggioni AP; Solomon SD; Swedberg K; Van de Werf F; White H; Leimberger JD; Henis M; Edwards S; Zelenkofske S; Sellers MA; Califf RM;
N Engl J Med; 2003 Nov; 349(20):1893-906. PubMed ID: 14610160
[TBL] [Abstract][Full Text] [Related]
22. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Hawkins NM; Huang Z; Pieper KS; Solomon SD; Kober L; Velazquez EJ; Swedberg K; Pfeffer MA; McMurray JJ; Maggioni AP;
Eur J Heart Fail; 2009 Mar; 11(3):292-8. PubMed ID: 19176539
[TBL] [Abstract][Full Text] [Related]
23. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
Giannuzzi P; Temporelli PL; Marchioli R; Maggioni AP; Balestroni G; Ceci V; Chieffo C; Gattone M; Griffo R; Schweiger C; Tavazzi L; Urbinati S; Valagussa F; Vanuzzo D;
Arch Intern Med; 2008 Nov; 168(20):2194-204. PubMed ID: 19001195
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.
Moukarbel GV; Signorovitch JE; Pfeffer MA; McMurray JJ; White HD; Maggioni AP; Velazquez EJ; Califf RM; Scheiman JM; Solomon SD
Eur Heart J; 2009 Sep; 30(18):2226-32. PubMed ID: 19556260
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose.
Mann DL; Deswal A
N Engl J Med; 2003 Nov; 349(20):1963-5. PubMed ID: 14610159
[No Abstract] [Full Text] [Related]
26. High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Anderson RE; Pfeffer MA; Thune JJ; McMurray JJ; Califf RM; Velazquez E; White HD; Rouleau JL; Skali H; Maggioni A; Solomon SD
Am Heart J; 2008 Apr; 155(4):706-11. PubMed ID: 18371480
[TBL] [Abstract][Full Text] [Related]
27. Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.
Prisant LM; Thomas KL; Lewis EF; Huang Z; Francis GS; Weaver WD; Pfeffer MA; McMurray JJ; Califf RM; Velazquez EJ
J Am Coll Cardiol; 2008 May; 51(19):1865-71. PubMed ID: 18466801
[TBL] [Abstract][Full Text] [Related]
28. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986
[No Abstract] [Full Text] [Related]
29. Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial.
Piccini JP; Zhang M; Pieper K; Solomon SD; Al-Khatib SM; Van de Werf F; Pfeffer MA; McMurray JJ; Califf RM; Velazquez EJ
Eur Heart J; 2010 Jan; 31(2):211-21. PubMed ID: 19854729
[TBL] [Abstract][Full Text] [Related]
30. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.
Inglis SC; Bebchuk J; Al-Suhaim SA; Case J; Pfeffer MA; Solomon SD; Hou YR; Pitt B; Dargie HJ; Ford I; Kjekshus J; Zannad F; Dickstein K; McMurray JJ
Int J Cardiol; 2013 Sep; 168(2):1094-101. PubMed ID: 23194780
[TBL] [Abstract][Full Text] [Related]
31. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
Thomas KL; Al-Khatib SM; Lokhnygina Y; Solomon SD; Kober L; McMurray JJ; Califf RM; Velazquez EJ
Am Heart J; 2008 Jan; 155(1):87-93. PubMed ID: 18082495
[TBL] [Abstract][Full Text] [Related]
32. VALIANT trial results support use of valsartan in acute myocardial infarction.
Cardiovasc J S Afr; 2004; 15(1):45, 47. PubMed ID: 15095754
[No Abstract] [Full Text] [Related]
33. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
34. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI
Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979
[TBL] [Abstract][Full Text] [Related]
35. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
[TBL] [Abstract][Full Text] [Related]
36. Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.
Anavekar NS; Solomon SD; McMurray JJ; Maggioni A; Rouleau JL; Califf R; White H; Kober L; Velazquez E; Pfeffer MA
Am J Cardiol; 2008 Apr; 101(7):925-9. PubMed ID: 18359309
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life after myocardial infarction is associated with level of left ventricular ejection fraction.
Pettersen KI; Kvan E; Rollag A; Stavem K; Reikvam A
BMC Cardiovasc Disord; 2008 Oct; 8():28. PubMed ID: 18847506
[TBL] [Abstract][Full Text] [Related]
38. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
Sumner G; Salehian O; Yi Q; Healey J; Mathew J; Al-Merri K; Al-Nemer K; Mann JF; Dagenais G; Lonn E;
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of captopril therapy after myocardial infarction.
Tsevat J; Duke D; Goldman L; Pfeffer MA; Lamas GA; Soukup JR; Kuntz KM; Lee TH
J Am Coll Cardiol; 1995 Oct; 26(4):914-9. PubMed ID: 7560617
[TBL] [Abstract][Full Text] [Related]
40. Interpreting parental proxy reports of (health-related) quality of life for children with unilateral cochlear implants.
Sach TH; Barton GR
Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):435-45. PubMed ID: 17161471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
